A randomized, double-blind, placebo-controlled study of the effect of ezetimibe on glucose metabolism in subjects with type 2 diabetes mellitus and hypercholesterolemia

被引：0
|
作者：
Itori Saito
Kyoichi Azuma
Taro Kakikawa
Nobuyuki Oshima
Mary E Hanson
Andrew M Tershakovec
机构：
[1] Clinical research,MSD KK, Japan development
[2] Merck & Co.,undefined
[3] Inc,undefined
来源：
Lipids in Health and Disease | / 14卷
关键词：
Fasting plasma glucose; Glycoalbumin; HbA1c; Japanese; LDL-C;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Effect of pramlintide on ad-libitum food intake in obese subjects and subjects with type 2 diabetes: A randomized, double-blind, placebo-controlled, crossover study
    Weyer, C
    Chapman, I
    Parker, B
    Doran, S
    Feinle-Bisset, C
    Wishart, J
    Wang, Y
    Burns, C
    Lush, C
    Horowitz, M
    OBESITY RESEARCH, 2004, 12 : A28 - A28
  • [32] Albiglutide does not impair the counter-regulatory hormone response to hypoglycaemia: a randomized, double-blind, placebo-controlled, stepped glucose clamp study in subjects with type 2 diabetes mellitus
    Hompesch, M.
    Jones-Leone, A.
    Carr, M. C.
    Matthews, J.
    Zhi, H.
    Young, M.
    Morrow, L.
    Reinhardt, R. R.
    DIABETES OBESITY & METABOLISM, 2015, 17 (01): : 82 - 90
  • [33] Results of a randomized, double-blind, placebo-controlled study administering glimepiride to patients with type 2 diabetes mellitus inadequately controlled with rosiglitazone monotherapy
    McCluskey, D
    Touger, MS
    Melis, R
    Schleusener, DS
    CLINICAL THERAPEUTICS, 2004, 26 (11) : 1783 - 1790
  • [34] Validation of standardized polyherbal formulation in the management of type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial
    Shridhar Pandya
    Chetan Savaliya
    Kamlesh Thummar
    Amol Gothwad
    Tanuja Panchabhai
    Dheeraj Nagore
    Journal of Diabetes & Metabolic Disorders, 2023, 22 : 495 - 506
  • [35] Validation of standardized polyherbal formulation in the management of type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial
    Pandya, Shridhar
    Savaliya, Chetan
    Thummar, Kamlesh
    Gothwad, Amol
    Panchabhai, Tanuja
    Nagore, Dheeraj
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2023, 22 (01) : 495 - 506
  • [36] Effect of Cilostazol on Lipid, Uric Acid and Glucose Metabolism in Patients with Impaired Glucose Tolerance or Type 2 Diabetes MellitusA Double-Blind, Placebo-Controlled Study
    Takayoshi Toyota
    Shinichi Oikawa
    Ryuzo Abe
    Ryuichi Sano
    Norihiro Suzuki
    Shigeru Hisamichi
    Akira Fukao
    Clinical Drug Investigation, 2001, 21 : 325 - 335
  • [37] Randomized, double-blind, placebo-controlled, clinical study on the effect of Diabetinol® on glycemic control of subjects with impaired fasting glucose
    Evans, Malkanthi
    Judy, William V.
    Wilson, Dale
    Rumberger, John A.
    Guthrie, Najla
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2015, 8 : 275 - 285
  • [38] Effect of Theaflavin on Oral Bacteria in Japanese Subjects: A Randomized, Placebo-Controlled, Double-Blind Study
    Katanasaka, Yasufumi
    Yoshida, Naoki
    Naitou, Hirotaka
    Naruta, Ryuya
    Miyazaki, Yusuke
    Sunagawa, Yoichi
    Funamoto, Masafumi
    Shimizu, Kana
    Shimizu, Satoshi
    Sari, Numila
    Yamakage, Hajime
    Satoh-Asahara, Noriko
    Hasegawa, Koji
    Morimoto, Tatsuya
    JOURNAL OF MEDICINAL FOOD, 2021, 24 (11) : 1186 - 1190
  • [39] Comments on 'Effect of pioglitazone on testosterone in eugonadal men with type 2 diabetes mellitus: a randomized double-blind placebo controlled study'
    Kumar, Manoj
    Thukral, Anubhav
    Jain, Rajesh
    Chaudhary, Sandeep
    Mukherjee, Satinath
    Chowdhury, Subhankar
    CLINICAL ENDOCRINOLOGY, 2014, 80 (01) : 157 - 157
  • [40] Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus
    Nobuya Inagaki
    Shin-ichi Harashima
    Nobuko Maruyama
    Yutaka Kawaguchi
    Maki Goda
    Hiroaki Iijima
    Cardiovascular Diabetology, 15
12345